Jeffrey M. Leiden - 25 Jul 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Executive Chairman, Director
Signature
/s/ Joy Liu, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
25 Jul 2022
Net transactions value
-$31,670,341
Form type
4
Filing time
27 Jul 2022, 16:17:44 UTC
Previous filing
14 Apr 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $5,494,139 +60,342 +81% $91.05 134,502 25 Jul 2022 Direct
transaction VRTX Common Stock Sale $3,875,553 -13,869 -10% $279.44 120,633 25 Jul 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale $9,247,444 -32,983 -27% $280.37 87,650 25 Jul 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale $9,588,494 -34,090 -39% $281.27 53,560 25 Jul 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale $11,485,298 -40,666 -76% $282.43 12,894 25 Jul 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale $2,967,691 -10,471 -81% $283.42 2,423 25 Jul 2022 Direct F1, F2, F7
holding VRTX Common Stock 440 25 Jul 2022 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -60,342 -64% $0.000000 33,524 25 Jul 2022 Common Stock 60,342 $91.05 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
F2 Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $279.44 (range $278.90 to $279.89).
F4 Open market sales reported on this line occurred at a weighted average price of $280.37 (range $279.90 to $280.88).
F5 Open market sales reported on this line occurred at a weighted average price of $281.27 (range $280.90 to $281.89).
F6 Open market sales reported on this line occurred at a weighted average price of $282.43 (range $281.90 to $282.89).
F7 Open market sales reported on this line occurred at a weighted average price of $283.42 (range $282.90 to $283.84).
F8 Fully vested.